Capha Pharmaceuticals Inc. Stock Other OTC

Stocks

31/07/25	Capha Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
28/05/25	Capha Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
24/04/25	Capha Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24/04/25	Capha Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt	CI
17/10/24	Capha Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
29/07/24	Capha Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
30/05/24	Capha Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
26/04/24	Capha Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
26/04/24	Capha Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt	CI
28/11/23	Capha Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
28/08/23	Capha Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
30/05/23	Capha Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
26/04/23	Capha Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	CI

Manager	Title	Age	Since
James Brown CEO	Chief Executive Officer	-	13/01/2004

Director	Title	Age	Since
Janice Brown BRD	Director/Board Member	-	13/01/2004
Herbert Leary BRD	Director/Board Member	-	25/10/2010
James Brown CHM	Chairman	-	31/10/2002

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CAPHA PHARMACEUTICALS INC.	-.--%	-.--%	-	-	64
ELI LILLY AND COMPANY	+1.08%	-3.93%	+48.03%	+160.13%	1,043B
JOHNSON & JOHNSON	+1.19%	-3.52%	+51.70%	+56.36%	602B
ABBVIE INC.	+4.21%	+1.79%	+33.48%	+87.04%	449B
ROCHE HOLDING AG	+0.56%	-1.28%	+29.30%	+23.90%	327B
NOVARTIS AG	+0.95%	-0.26%	+32.80%	+45.97%	279B
ASTRAZENECA PLC	-0.20%	-2.48%	+21.37%	+22.71%	264B
AMGEN INC.	+3.70%	+2.19%	+24.27%	+63.38%	201B
GILEAD SCIENCES, INC.	+3.49%	+1.08%	+24.08%	+76.58%	169B
PFIZER INC.	+1.29%	+3.67%	+2.15%	-30.78%	143B
Average	+1.37%	-0.68%	+29.69%	+56.14%	386.34B
Weighted average by Cap.	+1.64%	-1.82%	+37.35%	+82.80%